Suvoda and Greenphire Merge; Thoma Bravo Leads Investment

April 24, 2025

Suvoda and Greenphire have completed a merger to form a unified clinical-trial technology company operating under the Suvoda name. Thoma Bravo is the lead strategic investor in the combined business, with Bain Capital Tech Opportunities and LLR Partners taking significant minority stakes to support the expanded end-to-end platform for sponsors, sites, and patients.

Buyers
Thoma Bravo, Bain Capital Tech Opportunities Fund, LLR Partners
Targets
Suvoda, Greenphire
Location
Pennsylvania, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.